Loading...
Loading...
Available on 1 platform
Sign in to view source links and access this dataset
Nine observational studies involving 3,799 participants were synthesized to investigate the association between fibroblast growth factor 23 (FGF23) and diabetic kidney disease (DKD). The meta-analysis, conducted by Xingjia Wang and published on figshare in 2026, found serum FGF23 levels were significantly elevated in DKD patients compared to non-DKD controls. The study followed PRISMA guidelines and its protocol was registered with PROSPERO (CRD420251180089).
The primary file is a DOCX document (19.1 KB) containing the review manuscript; users seeking the underlying trial data must locate the original nine studies.